News

The Hague, Netherlands, May 31, 2023: Amber Implants has achieved a significant milestone by obtaining regulatory approval for our clinical study in Europe. This remarkable achievement...

At the start of this year we announced that Ambre Implants was granted a subsidy of 500.000 Euro in the framework of the Kansen voor West programme....

The Hague, Netherlands, July 6, 2022: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces that it has...

Today is an exciting day for Amber Implants! We are proud to announce that our product, the VCFix® Spinal System, has successfully passed all preclinical...

Polymers are particularly attractive in the medical device field due to their biocompatibility, mechanical properties comparable to those of the host tissues, and customizable manufacturing...

The Hague, Netherlands, 19 January 2022: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the successful...

Currently more than 70% of clinically used implants are made from metallic materials, such as stainless steel, cobalt chromium alloys, titanium alloys and others. However,...

The Hague, Netherlands, 5 October 2021: Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces its VCFix®...

Since medical devices directly affect the human body, safety is more important than non-medical industrial products. Each country has established standards and regulations to ensure...